Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „given“
Suchtreffer
Begriffe & Kennungen
Imfinzi · 4.8 · IMFINZI in combination with tremelimumab 300 mg The safety of IMFINZI given in combination with a single dose
Eintrag öffnenImfinzi · 4.8 · IMFINZI in combination with tremelimumab 75 mg and platinum-based chemotherapy The safety of IMFINZI given in
Eintrag öffnenIncrelex · 4.3 · As INCRELEX contains benzyl alcohol, it must not be given to premature babies or neonates.
Eintrag öffnenIncresync · 4.8 · In active comparator-controlled studies, mean weight increase with pioglitazone given as monotherapy was 2-3 k
Eintrag öffnenInfanrix Hexa · 4.5 · Infanrix hexa can be given concomitantly with pneumococcal conjugate vaccines (PCV7, PCV10 and PCV13), meningo
Eintrag öffnenIntuniv · 4.5 · Guanfacine causes a decrease in heart rate. Given the effect of guanfacine on heart rate, the concomitant use
Eintrag öffnenInvega · 4.5 · Given the primary CNS effects of paliperidone (see section 4.8), INVEGA should be used with caution in combina
Eintrag öffnenIsentress · 4.5 · (chelation of metal ions) Other METAL CATION Iron salts Expected: Given simultaneously iron salts Raltegravir
Eintrag öffnenIsentress · 4.5 · Given that raltegravir is metabolised primarily via UGT1A1, caution should be used when co-administering ralte
Eintrag öffnenIsentress · 4.5 · Given that raltegravir is metabolised primarily via UGT1A1, caution should be used when co-administering ralte
Eintrag öffnenIsentress · 4.5 · Given that raltegravir is metabolised primarily via UGT1A1, caution should be used when co-administering ralte
Eintrag öffnenIsentress · 4.5 · Other METAL CATION Iron salts Expected: Given simultaneously iron salts Raltegravir AUC are expected to redu
Eintrag öffnenItuxredi · 4.8 · Haematologic adverse reactions In clinical trials with rituximab monotherapy given for 4 weeks, haematological
Eintrag öffnenIvemend · 4.5 · Fosaprepitant 150 mg, given as a single dose, is a weak inhibitor of CYP3A4. Fosaprepitant does not seem to in
Eintrag öffnenIvemend · 4.8 · The frequency categories given in the table are based on the studies in adults; the observed frequencies in th
Eintrag öffnenIxiaro · 4.8 · Table 1: Frequency of adverse reactions observed in children given the 0.25 ml dose (2 months to <3 years of a
Eintrag öffnenJakavi · 4.5 · In healthy subjects given ruxolitinib (50 mg single dose) following the potent CYP3A4 inducer rifampicin (600
Eintrag öffnenJakavi · 4.5 · In healthy subjects given ruxolitinib (50 mg single dose) following the potent CYP3A4 inducer rifampicin (600
Eintrag öffnenJanumet · 4.5 · Glucocorticoids (given by systemic and local routes) beta-2-agonists, and diuretics have intrinsic hyperglycae
Eintrag öffnenJemperli · 4.8 · Adverse reactions known to occur with dostarlimab as monotherapy, or with carboplatin or paclitaxel given alon
Eintrag öffnen